Despite the stunning progress in medical research that has been achieved over the past few decades, heart disease remains the leading cause of death and disability among adults in many industrialized countries. Behavioral and psychosocial factors play important roles in the development and progression of heart disease, as well as in how patients adapt to the challenges of living with this illness. This volume in the series "Advances in Psychotherapy" provides readers with a succinct introduction to behavioral and psychosocial treatment of the two most prevalent cardiac conditions, coronary heart disease and congestive heart failure. It summarizes the latest research on the intricate relationships between these conditions and psychosocial factors such as stress, depression, and anger, as well as behavioral factors such as physical inactivity and non-adherence to cardiac medication regimens. It draws upon lessons learned from a wide range of studies, including the landmark ENRICHD and SADHART clinical trials. It then goes on to provide practical, evidence-based recommendations and clinical tools for assessing and treating these problems. "Heart Disease" is an indispensable treatment manual for professionals who work with cardiac patients.
Behavioral medicine emerged in the 1970s as the interdisciplinary field concerned with the integration of behavioral, psychosocial, and biomedical science knowledge relevant to the understanding of health and illness, and the application of this knowledge to prevention, diagnosis, treatment, and rehabilitation. Recent years have witnessed an enormous diversification of behavioral medicine, with new sciences (such as genetics, life course epidemiology) and new technologies (such as neuroimaging) coming into play. This book brings together such new developments by providing an up-to-date compendium of methods and applications drawn from the broad range of behavioral medicine research and practice. The book is divided into 10 sections that address key fields in behavioral medicine. Each section begins with one or two methodological or conceptual chapters, followed by contributions that address substantive topics within that field. Major health problems such as cardiovascular disease, cancer, HIV/AIDs, and obesity are explored from multiple perspectives. The aim is to present behavioral medicine as an integrative discipline, involving diverse methodologies and paradigms that converge on health and well being.
This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to “speak the language of medicine” through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.
Despite the stunning progress in medical research that has been achieved over the past few decades, heart disease remains the leading cause of death and disability among adults in many industrialized countries. Behavioral and psychosocial factors play important roles in the development and progression of heart disease, as well as in how patients adapt to the challenges of living with this illness. This volume in the series "Advances in Psychotherapy" provides readers with a succinct introduction to behavioral and psychosocial treatment of the two most prevalent cardiac conditions, coronary heart disease and congestive heart failure. It summarizes the latest research on the intricate relationships between these conditions and psychosocial factors such as stress, depression, and anger, as well as behavioral factors such as physical inactivity and non-adherence to cardiac medication regimens. It draws upon lessons learned from a wide range of studies, including the landmark ENRICHD and SADHART clinical trials. It then goes on to provide practical, evidence-based recommendations and clinical tools for assessing and treating these problems. "Heart Disease" is an indispensable treatment manual for professionals who work with cardiac patients.
This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to “speak the language of medicine” through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.
This book provides clear guidance about effective, evidence-based approaches to treating alcohol misuse in young adults. Heavy drinking – and its associated problems – are an integral part of many college students' and other young adults' lives. Though some young drinkers are able to consume alcohol without incident, many face significant negative fallout from their excessive consumption. This volume in the series Advances in Psychotherapy: Evidence-Based Practice describes the nature of alcohol misuse, its epidemiology, its causes, and methods for treatment, specifically as they pertain to college students and other young adults. It provides practitioners and trainees with a range of evidence-based treatment approaches to help clients change their alcohol use habits. The information presented is both thorough and concise and will help readers with varied backgrounds and experience improve their understanding of the many nuanced factors involved in assessing and treating problematic drinking in young adults.
Peer into the Edge of Forever Stories and Reflections on the Meaning of Extraordinary Experiences Premonitions of death, near-death experiences, and afterlife communication are common, but they can be difficult to talk about and understand. Dr. Kenneth Doka—a world-renowned expert on death, dying, and bereavement—explores hundreds of real-life examples as well as fascinating research on unusual phenomena related to the dying process. Sharing stories from his own practice as a counselor and minister, as well as stories from friends, colleagues, and clinicians, Dr. Doka helps you come to your own understanding of what these experiences mean. With in-depth examinations of death coincidences, terminal lucidity, reincarnation, and more, this book provides meaningful answers for anyone who has struggled with the grief of losing a loved one. With a deep sense of empathy and compassion, this book's insights support you as you integrate these phenomena and cope with the profound emotions that accompany life's final transition.
The classic trauma surgery text! This comprehensive and authoritative reference text covers prevention and pre-hospital care transport through trauma "scoring" as well as operative and non-operative management. Known for its current and practical coverage, the book features a commentary for each chapter written by a leading expert in the field.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.